JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01904-07v1
46/3/837    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Yu, X.-F.
Right arrow Articles by Huang, Z.-C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, X.-F.
Right arrow Articles by Huang, Z.-C.
Journal of Clinical Microbiology, March 2008, p. 837-841, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.01904-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Preparation of Armored RNA as a Control for Multiplex Real-Time Reverse Transcription-PCR Detection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus{triangledown}

Xin-Fen Yu,* Jing-Cao Pan, Rong Ye, Hai-Qing Xiang, Yu Kou, and Zhi-Cheng Huang

Microbiology Laboratory, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang 310006, People's Republic of China

Received 24 September 2007/ Returned for modification 9 November 2007/ Accepted 13 December 2007

The common respiratory viruses, including influenza A, influenza B, and newly emerging severe acute respiratory syndrome (SARS) viruses, may cause similar clinical symptoms. Therefore, differential diagnosis of these virus pathogens is frequently required for single clinical samples. In addition, there is an urgent need for noninfectious and stable RNA standards and controls for multivirus detection. In this study, reverse transcription-PCR (RT-PCR) targeting of the RNAs of influenza A and influenza B viruses and SARS coronavirus was performed, and the resulting products were spliced into a fragment which was packaged into armored RNA for use as a noninfectious, quantifiable synthetic substitute. Furthermore, in the present study we developed a multiplex real-time RT-PCR assay in which the armored RNA was used as an external positive control and the three RNA viruses could be detected simultaneously in a single reaction mix. The detection limit of the multiplex real-time PCR was 10 copies/µl of armored RNA.


* Corresponding author. Mailing address: Microbiology Laboratory, Hangzhou Center for Disease Control and Prevention, No. 277, Wu Lin Road, Hangzhou, People's Republic of China. Phone: 86-571-85177730. Fax: 86-571-85165007. E-mail: yuxinfen{at}hotmail.com

{triangledown} Published ahead of print on 26 December 2007.


Journal of Clinical Microbiology, March 2008, p. 837-841, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.01904-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.